SCHEMBL20708587

SCHEMBL20708587

Cc1cc(C2(CCC(=O)N3CCN(c4cc(F)cc(F)c4)CC3)NC(=O)NC2=O)ccn1

nearest known ligand 0.76

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ ADAMTS5 Q9UNA0 20/20 0.76
▸ ADAMTS4 O75173 1/20 0.63
▸ MMP2 P08253 7/20 0.61
▸ MMP13 P45452 6/20 0.61
▸ ADAM17 P78536 6/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17871463 0.86 ADAMTS5 (1.00) ADAMTS5MMP2
SCHEMBL21582774 0.83 ADAMTS5 (0.76) ADAMTS5ADAMTS4MMP2MMP13ADAM17
SCHEMBL20708446 0.83 ADAMTS5 (0.86) ADAMTS5ADAMTS4MMP2MMP13ADAM17
SCHEMBL20708334 0.82 ADAMTS5 (0.73) ADAMTS5ADAMTS4MMP2MMP13ADAM17
SCHEMBL21582749 0.81 ADAMTS5 (0.75) ADAMTS5ADAMTS4MMP2MMP13ADAM17
SCHEMBL20708305 0.81 ADAMTS5 (0.74) ADAMTS5ADAMTS4MMP2MMP13ADAM17
SCHEMBL19996267 0.80 ADAMTS5 (1.00) ADAMTS5ADAMTS4MMP2MMP13ADAM17
SCHEMBL20708670 0.80 ADAMTS5 (0.76) ADAMTS5ADAMTS4MMP2MMP13ADAM17
SCHEMBL20708324 0.80 ADAMTS5 (0.76) ADAMTS5ADAMTS4MMP2MMP13ADAM17
SCHEMBL20708684 0.79 ADAMTS5 (0.76) ADAMTS5ADAMTS4MMP2MMP13ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3575294-A1 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS Les Laboratoires Servier (FR) 2019-12-04 — — EP disclosed
EP-3237406-B1 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS GALAPAGOS NV (BE) 2019-02-06 — — EP disclosed
Send feedback